Tratopedia
Side N繁中
Settings

Text size

Language

Theme

High contrast

Version

v1.230.2

The release this page was built from. It is what the service worker caches under.

Side N

Bruker’s spatial biology division: NanoString, Canopy and Acuity

Which sources back which section of this article, and what its evidence base looks like.

Which sources back which section

SectionSources behind it
What happenedBruker’s release of 9 Oct 2024, its 10-Qs for Q3 2020, Q3 2025 and Q2 2026, its 2025 10-K and its April 2024 exhibit; NanoString’s 8-Ks on the verdict, the bankruptcy and the sale; 10x’s settlement 8-K; SelectScience on Acuity; Bruker’s AGBT 2026 and AACR 2026 releases; the Q2 2026 call transcript.
TimelineThe same documents, dated; plus NanoString’s S-1/A and 10-Qs for Q1 and Q3 2023, its December 2023 reduction-in-force 8-K and its UPC appeal release; BioSTL and Bruker’s 2020 release on Canopy; Canopy’s CellScape release; the PhenomeX agreement; 10x’s Q1 2024 10-Q, injunction release and Atera release; Bruker’s AGBT 2025 release; GEN’s 2026 ranking; Zacks on Atera shipments.
The argumentNanoString’s Q3 2023 10-Q, its 2022 results release and its verdict 8-K; Bruker’s April 2024 exhibit and Q2 2026 10-Q; 10x’s settlement 8-K, its Q3 2025 10-Q and its injunction release; GEN’s interview of October 2024; the Q1 2026 call transcript.
What others addBruker’s AGBT 2025, AGBT 2026 and AACR 2026 releases and the Beacon blog; Canopy’s CellScape release; NanoString’s Q1 2023 10-Q; the PhenomeX agreement; Bruker’s 2025 10-K, 10-Qs for Q3 2025 and Q2 2026, and its three 2026 results releases; both call transcripts; 10x’s 2025 10-K and Atera release; GEN’s interview and ranking; Zacks; DeciBio.
ConclusionBruker’s Q2 2026 10-Q, 2025 10-K and April 2024 exhibit; its AGBT 2026 and AACR 2026 releases; the Q2 2026 call transcript; GEN’s 2026 ranking; the Atera release and Zacks; DeciBio.

What the evidence base looks like

  • 40Sources used on the page
  • 21That are regulatory filings or exhibits to them
  • 2Read through a reader service after a direct request was refused; the rest read directly
  • 21Links approached and refused, or read and not used
FunctionHow manyWhat they are
Vendor32The companies themselves: Bruker’s, NanoString’s and 10x’s filings, Bruker’s, Canopy’s, NanoString’s and 10x’s press releases, and a Bruker blog.
Reporting6Trade journalism, two call transcripts and an investment-research summary.
Origin1The founding investor’s own announcement of a sale it was party to.
Reference1A market-research seller’s report page.

Reliable

Reliable, but with an interestWorth believing and reliableWeak on both, and used with careHonest, but thin

Worth believing

Each point is one source used, placed by two judgements on a six-step scale. Points carry no names: the chart shows the shape of the evidence, not a verdict on any publisher.